68 companies

Showing 1–24 of 68 companies

RA Capital

RA Capital funds and builds healthcare and life science companies.

Novartis

Novartis is a Basel-headquartered global pharmaceutical company developing innovative medicines, employing approximately 109,000 people and reaching over 280 million patients worldwide.

2 open jobs

Libris Innovations

Libris Innovations is the for-profit subsidiary of the Indiana Biosciences Research Institute, advancing its research toward potential medicines and life-science innovations.

1 open job

Servier

Servier is an independent global pharmaceutical group governed by a non-profit foundation, developing medicines in oncology, cardiovascular and rare neurological diseases.

1 open job

Luma Group

Fueling the future of human health and longevity with cutting-edge innovations.

1 open job

Taiho Ventures

Corporate venture arm of Taiho Pharmaceutical, founded 2016, investing $400m in early-stage biotech and forming companies, including pipeline spinouts.

Excelerate Health Ventures

Durham-based venture capital firm investing $500K–$2M in seed and Series A B2B Pharma Tech and tech-enabled pharmaceutical services companies, with 19 investments and 8 strategic exits.

Roche

Roche is the world's largest biotech company and a leading provider of in-vitro diagnostics, and invests in biotechnology and healthcare startups through Roche Venture Fund.

Chiesi Group

Chiesi Ventures invests in early-stage rare disease therapies and technologies; it is the venture arm of Chiesi Group, a Parma-based biopharmaceutical group active in 31 countries.

UCB

UCB is a Brussels-headquartered biopharmaceutical company focused on neurology and immunology, investing in early-stage life-sciences companies through UCB Ventures.

Jeito Capital

Independent Paris-headquartered investment firm financing clinical-stage biopharma companies and supporting them across drug development, regulatory, manufacturing and commercialisation.

AstraZeneca

AstraZeneca is a global biopharmaceutical company that researches, develops, and commercializes prescription medicines in oncology, respiratory, and rare diseases.

HealthCap

HealthCap is a family of venture capital funds investing globally in life sciences.

ESB Invest

Zuerst die Gründer und die Idee. Dann die Investoren.

Johnson & Johnson

Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years.

Venrock

Build the future.

Air Street Capital

Investing in AI-first companies.

TruVenturo

TruVenturo is one of Germany’s most successful internet company builders and independent investors. At TruVenturo, passionate entrepreneurs share the common vision to build innovative digital businesses and products. Our industry leaders scale promising new tech ventures and a...

Santé

Santé invests at the leading edge of innovation in healthcare and technology. We manage approximately one billion dollars of capital in two separate strategies.

Novo Ventures

We are a life science venture capital investor, delivering knowledge, network, and capital to companies.

82VS

We are a venture studio leveraging Alloy’s pre-competitive drug discovery platforms. Established drug discovery, scientific, and lab resources allow entrepreneurs to start their first experiment on day one.

SM-Sino Technology Investment

We identify, invest and nurture biotech companies that make a difference in healthcare.

SymBiosis

We are long-term investors in engineering biology to treat - or better, cure - human disease.

Epidarex Capital

Epidarex is a transatlantic venture capital firm led by a diverse team of early-stage investors building breakthrough life science companies in emerging hubs.

68 companies

RA Capital

Novartis

Libris Innovations

Servier

Luma Group

Taiho Ventures

Excelerate Health Ventures

Roche

Chiesi Group

UCB

Jeito Capital

AstraZeneca

HealthCap

ESB Invest

Johnson & Johnson

Venrock

Air Street Capital

TruVenturo

Santé

Novo Ventures

82VS

SM-Sino Technology Investment

SymBiosis

Epidarex Capital

Browse by market